Trial intelligence / Profile preview

Pregabalin versus levetiracetam adjunctive therapy study in refractory partial seizures

2007-001458-22Phase 3Completed

Sponsor
Pfizer
Start
Jun 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in epilepsy and intractable epilepsy (IE) comparing Pregabalin adjunctive therapy with Levetiracetam adjunctive therapy (2 arms). Primary endpoint: Responder rate. Started Jun 2007; status: completed.

02

Drugs

pregabalinlevetiracetam
03

Conditions

epilepsyintractable epilepsy (IE)

Beyond the preview

Go deeper on 2007-001458-22.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-001458-22.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call